Biocon Ltd (BION.NS)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|64||Executive Non-Independent Chairman of the Board, Managing Director|
|53||2014||Chief Executive Officer, Joint Managing Director, Executive Director|
|68||2017||Non-Executive Vice Chairman of the Board|
|2014||Chief Financial Officer|
|58||CEO & Director of Syngene|
- BRIEF-India's Biocon Says U.S. FDA Completed Pre-Approval Inspection At Malaysia Unit
- BRIEF-Cytosorbents Expands Its Partnership With Biocon To Launch Cytosorb In Malaysia
- BRIEF-Mylan And Biocon Receive Positive CHMP Opinion For Semglee, Biosimilar Insulin Glargine
- Indian shares snap six-day winning streak; bonds fall
- India's Biocon Q3 profit plunges 46 pct